Skip to main content

Table 1 Comparison of demographic and clinical characteristics stratified by dyslipidemia

From: Evaluation of alterations in serum immunoglobulin concentrations in components of metabolic syndrome, obesity, diabetes, and dyslipidemia

 

Total

Dyslipidemia

No dyslipidemia

P-value

Age, years (SD)

62 (19)

70 (13)

59 (20)

<  0.0001

Female, n (%)

899 (50)

260 (47)

639 (51)

0.1894

BMI, kg/m2 (SD)

29 (13)

30 (14)

29 (13)

0.0727

Race

 White, n (%)

1181 (65)

378 (69)

803 (64)

0.0016

 Black, n (%)

251 (14)

66 (12)

185 (15)

 Asian, n (%)

133 (7)

51 (9)

82 (7)

 Other, n (%)

244 (13)

54 (10)

190 (15)

Comorbidities

 Diabetes, n (%)

603 (33)

254 (46)

349 (28)

<  0.0001

 Obesity, n (%)

588 (33)

203 (37)

385 (31)

0.0073

 CCI (SD)

3.1 (2.6)

3.5 (2.6)

2.9 (2.6)

<  0.0001

Immunoglobulin Concentrations

 IgA, mg/dL(SD)

260 (239)

251 (187)

264 (260)

0.2868

 IgG, mg/dL(SD)

1099 (629)

997 (485)

1144 (677)

<  0.0001

 IgM, mg/dL(SD)

112 (256)

106 (214)

115 (273)

0.5096